Phase 3 Epileptic Encephalopathy Clinical Trials
4 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–4 of 4 trials
Recruiting
Phase 3
A Clinical Trial for Participants With DEE to Assess Efficacy, Safety, Tolerability, and PK of Relutrigine
Developmental and Epileptic Encephalopathy 1
Praxis Precision Medicines160 enrolled11 locationsNCT07010471
Recruiting
Phase 3
A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathies (DEE)
Developmental and Epileptic Encephalopathy
Longboard Pharmaceuticals320 enrolled109 locationsNCT06719141
Recruiting
Phase 3
A Clinical Trial of Elsunersen in Pediatric SCN2A-DEE to Assess Efficacy and Safety
Epileptic EncephalopathySCN2A Encephalopathy
Praxis Precision Medicines50 enrolled2 locationsNCT07019922
Not Yet Recruiting
Phase 2Phase 3
Effectiveness and safety of riluzole for the treatment of seizures in individuals with SCN8A developmental and epileptic encephalopathy (SCN8A-DEE).
SCN8A developmental and epileptic encephalopathy
University of Melbourne5 enrolled1 locationACTRN12625000845437